121 related articles for article (PubMed ID: 12959433)
1. Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2.
Otsuka G; Saito K; Nagatani T; Yoshida J
J Neurosurg; 2003 Sep; 99(3):480-3. PubMed ID: 12959433
[TBL] [Abstract][Full Text] [Related]
2. Characterization of early onset neurofibromatosis type 2.
Matsuo M; Ohno K; Ohtsuka F
Brain Dev; 2014 Feb; 36(2):148-52. PubMed ID: 23414620
[TBL] [Abstract][Full Text] [Related]
3. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.
Baser ME; Makariou EV; Parry DM
J Neurosurg; 2002 Feb; 96(2):217-22. PubMed ID: 11838793
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.
Bosch MM; Boltshauser E; Harpes P; Landau K
Am J Ophthalmol; 2006 Jun; 141(6):1068-1077. PubMed ID: 16765675
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
7. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.
Parry DM; Eldridge R; Kaiser-Kupfer MI; Bouzas EA; Pikus A; Patronas N
Am J Med Genet; 1994 Oct; 52(4):450-61. PubMed ID: 7747758
[TBL] [Abstract][Full Text] [Related]
9. Population Characteristics and Progressive Disability in Neurofibromatosis Type 2.
Iwatate K; Yokoo T; Iwatate E; Ichikawa M; Sato T; Fujii M; Sakuma J; Saito K
World Neurosurg; 2017 Oct; 106():653-660. PubMed ID: 28720529
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
11. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
[TBL] [Abstract][Full Text] [Related]
12. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
[TBL] [Abstract][Full Text] [Related]
13. Intracranial meningiomas and neurofibromatosis type 2.
Aboukais R; Zairi F; Baroncini M; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 Jun; 155(6):997-1001; discussion 1001. PubMed ID: 23558725
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates.
Mathieu D; Kondziolka D; Flickinger JC; Niranjan A; Williamson R; Martin JJ; Lunsford LD
Neurosurgery; 2007 Mar; 60(3):460-8; discussion 468-70. PubMed ID: 17327790
[TBL] [Abstract][Full Text] [Related]
15. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
16. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
17. Meningiomas in children and adolescents: a meta-analysis of individual patient data.
Kotecha RS; Pascoe EM; Rushing EJ; Rorke-Adams LB; Zwerdling T; Gao X; Li X; Greene S; Amirjamshidi A; Kim SK; Lima MA; Hung PC; Lakhdar F; Mehta N; Liu Y; Devi BI; Sudhir BJ; Lund-Johansen M; Gjerris F; Cole CH; Gottardo NG
Lancet Oncol; 2011 Dec; 12(13):1229-39. PubMed ID: 22094004
[TBL] [Abstract][Full Text] [Related]
18. Presenting symptoms in children with neurofibromatosis type 2.
Gugel I; Grimm F; Teuber C; Zipfel J; Tatagiba M; Mautner VF; Schuhmann MU; Kluwe L
Childs Nerv Syst; 2020 Oct; 36(10):2463-2470. PubMed ID: 32537663
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]